Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick P Michel

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Handbook of Experimental Pharmacology|September 23, 2010
Methylxanthines and ryanodine receptor channelsSerge Guerreiro, Marc Marien, Patrick P Michel
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 2008
Atypical parkinsonism in the Caribbean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacinAnnie Lannuzel, Merle Ruberg, Patrick P Michel
Science'S STKE : Signal Transduction Knowledge Environment|April 28, 2006
Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?Patrick P Michel, Merle Ruberg, Etienne Hirsch
Molecular Pharmacology|October 1, 2013
The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasisErwann Rousseau, Patrick P Michel, Etienne C Hirsch
Neuron|May 20, 2016
Understanding Dopaminergic Cell Death Pathways in Parkinson DiseasePatrick P Michel, Etienne C Hirsch, Stéphane Hunot
Journal of Neurochemistry|May 12, 2010
KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasisDamien Toulorge, Serge Guerreiro, Etienne C Hirsch, et al.
Molecular Pharmacology|August 16, 2003
Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytesSophie Mourlevat, Jean-Denis Troadec, Merle Ruberg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 24, 2013
Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson diseasePatrick P Michel, Damien Toulorge, Serge Guerreiro, et al.
Molecular Pharmacology|August 4, 2005
Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanismBénédicte Salthun-Lassalle, Sabine Traver, Etienne C Hirsch, et al.
Journal of Neurochemistry|September 2, 2005
Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism: role of granulocyte macrophage colony-stimulating factorCarmen Henze, Andreas Hartmann, Thomas Lescot, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Handbook of Experimental Pharmacology|September 23, 2010
Methylxanthines and ryanodine receptor channelsSerge Guerreiro, Marc Marien, Patrick P Michel
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 2008
Atypical parkinsonism in the Caribbean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacinAnnie Lannuzel, Merle Ruberg, Patrick P Michel
Science'S STKE : Signal Transduction Knowledge Environment|April 28, 2006
Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?Patrick P Michel, Merle Ruberg, Etienne Hirsch
Molecular Pharmacology|October 1, 2013
The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasisErwann Rousseau, Patrick P Michel, Etienne C Hirsch
Neuron|May 20, 2016
Understanding Dopaminergic Cell Death Pathways in Parkinson DiseasePatrick P Michel, Etienne C Hirsch, Stéphane Hunot
Journal of Neurochemistry|May 12, 2010
KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasisDamien Toulorge, Serge Guerreiro, Etienne C Hirsch, et al.
Molecular Pharmacology|August 16, 2003
Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytesSophie Mourlevat, Jean-Denis Troadec, Merle Ruberg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 24, 2013
Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson diseasePatrick P Michel, Damien Toulorge, Serge Guerreiro, et al.
Molecular Pharmacology|August 4, 2005
Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanismBénédicte Salthun-Lassalle, Sabine Traver, Etienne C Hirsch, et al.
Journal of Neurochemistry|September 2, 2005
Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism: role of granulocyte macrophage colony-stimulating factorCarmen Henze, Andreas Hartmann, Thomas Lescot, et al.
Pageof 6